STOCKSCREENR

BMY

NYSE

Bristol-Myers Squibb Company

$60.59+3.00(+5.21%)Mkt Cap: $123.71B

Key Stats

Market Cap

$123.71B

P/E Ratio

17.51

EPS

$3.46

Dividend Yield

4.19%

52-Week Range

$42.52 — $62.89

Volume

23.49M

Avg Volume

12.29M

Beta

0.27

Price Alerts for BMY

Get alerted when BMY hits your target price.

$

Free — enter your email to get started

Valuation

P/E (TTM)

17.51

Forward P/E

9.68

PEG Ratio

1.05

P/S (TTM)

2.52

P/B (TTM)

6.58

P/FCF

15.34

EV/EBITDA

27.74x

EV/Sales

—

Financial Health

ROE (TTM)

0.39%

ROA (TTM)

0.08%

ROIC

0.05%

Gross Margin

0.68%

Operating Margin

0.26%

Net Margin

0.18%

Debt/Equity

2.55

Current Ratio

1.26

Growth

EPS Growth (YoY)

+0.81%

Revenue Growth (YoY)

+0.02%

EPS Growth (3Y)

-0.02%

EPS Growth (5Y)

+0.34%

Sales Growth (3Y)

+0.02%

Sales Growth (5Y)

+0.03%

EPS Est (This Year)

$6.26

EPS Est (Next Year)

$6.13

Dividends

Dividend Yield

—

Annual Dividend

$0.63

Payout Ratio

0.57%

Frequency

—

Ex-Dividend Date

2026-01-02

Cash/Share

$5.23

Analyst Consensus

2.0

Buy

1 = Strong Buy, 5 = Strong Sell

Price Target Range

$40.00$60.00$75.00
LowMedianHigh

Consensus Target: $62.73(3.5% upside)

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

2.04B

Float

2.03B

Free Float %

99.84%

Technicals

RSI (14)

76.95

SMA 20

$56.49

SMA 50

$54.48

SMA 200

$48.82

ATR (14)

1.43

Volatility (Week)

0.02%

Volatility (Month)

0.02%

Pattern

Doji

Performance

1 Day

+0.15%

1 Week

+8.70%

1 Month

+8.95%

3 Months

+30.35%

6 Months

+32.51%

1 Year

—

YTD

+13.84%

All-Time High

$63.33

About

Sector

Healthcare

Industry

Drug Manufacturers - General

Country

US

Exchange

NYSE

IPO Date

1972-06-01

Employees

34100

CEO

Christopher S. Boerner

Index Membership

S&P 500

Website

https://www.bms.com

Bristol-Myers Squibb Company (BMY) is a healthcare company in the drug manufacturers - general industry listed on the NYSE. With a market capitalization of $123.71B, a P/E ratio of 17.51, and a dividend yield of 4.19%, BMY is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare BMY against other stocks using dozens of fundamental and technical filters.

Similar Stocks

NVO

Novo Nordisk A/S

$42.22

+4.79%

$187.63B

AZN

AstraZeneca PLC

$187.37

+1.17%

$290.48B

MRK

Merck & Co., Inc.

$109.15

-1.62%

$269.59B

JNJ

Johnson & Johnson

$229.85

+1.10%

$553.30B

PFE

Pfizer Inc.

$26.70

+1.68%

$151.88B

ABBV

AbbVie Inc.

$211.33

+3.65%

$373.79B

Frequently Asked Questions

What is Bristol-Myers Squibb Company's P/E ratio?

Bristol-Myers Squibb Company (BMY) has a trailing twelve-month (TTM) P/E ratio of 17.51. This is near the market average range. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Bristol-Myers Squibb Company pay a dividend?

No, Bristol-Myers Squibb Company (BMY) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Bristol-Myers Squibb Company's market cap?

Bristol-Myers Squibb Company (BMY) has a market capitalization of $123.71 billion, classifying it as a large-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.

What do analysts think about BMY?

Wall Street analysts have a consensus "Buy" rating on Bristol-Myers Squibb Company (BMY) with an average score of 2.00 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell). The consensus price target of $62.73 implies 3.5% upside from the current price.

How has BMY performed this year?

Bristol-Myers Squibb Company (BMY) has returned +13.84% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.